Mudduwa Varanindu, Goodarzi Mohammad, Chalmers Richard, Khashaba Haitham
Department of Plastic and Reconstructive Surgery, University Hospital North Durham, Durham DH1 5TW, United Kingdom.
Department of Plastic and Reconstructive Surgery, University Hospital North Durham, Durham DH1 5TW, United Kingdom.
Int J Surg Case Rep. 2025 Feb;127:110922. doi: 10.1016/j.ijscr.2025.110922. Epub 2025 Jan 21.
Digital papillary adenocarcinoma (DPAC) is a rare malignant tumour of the sweat glands, usually in the digits. It has a high rate of recurrence and metastasis, yet there's a lack of guidelines for its diagnosis and management. Therefore, this report aims to evaluate procedures that provide the best outcomes, which will help create a consensus for its management.
This case report presents a 47-year old male who had a painless hyperkeratotic patch on his left index finger, with an additional cystic lesion underlying it. This was diagnosed as a hidradenoma, which later changed to DPAC. His finger was amputated through the head of the middle phalanx. A positive sentinel lymph node biopsy led to a left axillary lymph node dissection, which revealed micrometastasis. The patient declined radiotherapy and was on a melanoma follow-up plan. To date there is no evidence of recurrence.
Reviewing studies supported the use of immunohistochemical analysis to identify specific markers, especially HPV42. Sentinel lymph node biopsy and radical excision or amputation had the lowest rate of recurrence and thus should be common practice alongside long-term follow-up. Specific follow-up criteria are debated, yet this case may offer a solution by following the melanoma criteria.
Histological and immunohistochemical analysis (including HPV42 detection), SLNB, and radical excision or amputation are optimal for DPAC management. Long-term follow-up, possibly using melanoma criteria, is crucial. Further research is needed to establish definitive guidelines.
指状乳头状腺癌(DPAC)是一种罕见的汗腺恶性肿瘤,通常发生于手指。它具有较高的复发和转移率,但目前缺乏关于其诊断和治疗的指南。因此,本报告旨在评估能提供最佳治疗效果的方法,这将有助于就其治疗达成共识。
本病例报告呈现了一名47岁男性,其左手食指有一个无痛性角化过度斑块,其下方还有一个囊性病变。最初诊断为汗腺腺瘤,后来转变为DPAC。通过中指指骨头部对其手指进行了截肢。前哨淋巴结活检呈阳性,随后进行了左腋窝淋巴结清扫,结果显示存在微转移。患者拒绝放疗,目前按照黑色素瘤随访计划进行随访。迄今为止,尚无复发迹象。
回顾相关研究支持使用免疫组织化学分析来识别特定标志物,尤其是HPV42。前哨淋巴结活检以及根治性切除或截肢的复发率最低,因此应作为常规治疗方法并进行长期随访。关于具体的随访标准存在争议,但本病例可能通过遵循黑色素瘤标准提供一种解决方案。
组织学和免疫组织化学分析(包括HPV42检测)、前哨淋巴结活检以及根治性切除或截肢是DPAC治疗的最佳方法。长期随访,可能采用黑色素瘤标准,至关重要。需要进一步研究以建立明确的指南。